Microcystic Adnexal Carcinoma, from the CureRays guide library.

Microcystic adnexal carcinoma is a rare, slow-growing skin cancer — usually on the face — that almost never spreads but burrows deeply and along nerves, so it is treated with margin-controlled surgery and radiation for difficult cases.

What it is.

Microcystic adnexal carcinoma (MAC) is a rare skin cancer that arises from the sweat-gland and hair-follicle structures (the skin's adnexa). It most often appears on the face — especially the upper lip, cheek, and around the eyes — as a slow-growing, firm, flesh-colored or yellowish patch or plaque that can look deceptively bland, like a scar or a small area of thickened skin. Because it grows so quietly and resembles harmless conditions, it is frequently present for years before it is diagnosed. The defining behavior of MAC is the key to understanding its treatment: it is locally aggressive but almost never spreads to distant parts of the body. It sends out deep, finger-like extensions that burrow far beneath and beyond what can be seen or felt, and it has a strong tendency to grow along nerves (perineural invasion), which can cause numbness, tingling, or — when nerves of the face are involved — muscle weakness. This hidden, deep, and nerve-following growth is why MAC so often comes back after an incomplete removal and why simply cutting out the visible lesion is not enough. Because distant spread is so rare, the entire treatment strategy centers on completely clearing the tumor locally. That usually means margin-controlled surgery, in which the edges of the removed tissue are checked carefully under the microscope (often Mohs surgery) to trace and remove the hidden extensions while sparing as much of the face as possible. Radiation plays an important supporting role for tumors that cannot be fully removed, that have positive margins, or that show extensive nerve involvement.

How radiation treats it.

Radiation therapy treats microcystic adnexal carcinoma by delivering focused energy that damages the DNA inside the tumor cells so they lose the ability to grow and divide. The role of radiation follows directly from how this cancer behaves. MAC's defining traits are that it burrows far deeper and wider than it appears and that it tends to grow along nerves — and both of these make complete surgical removal challenging and make radiation, which can treat a broad area including microscopic and nerve-following disease, a valuable partner to surgery. The cornerstone of cure is margin-controlled surgery (often Mohs), which traces and removes the hidden extensions. Radiation is added in the situations where clearing the tumor surgically is uncertain: when the edges of the removed tissue come back close to or involved by cancer and further surgery isn't practical, radiation to the surgical area treats the microscopic cells left behind; and when the tumor has grown extensively along nerves, the radiation field can be extended along those nerve pathways toward their roots to treat disease that surgery cannot reach. Radiation can also be the primary treatment for a tumor that cannot be removed because of its size or location on the face. Because MAC almost never spreads to distant organs, the goal of radiation is local control — eradicating the disease in and around the original site and along the involved nerves — rather than treating the whole body. Modern techniques such as intensity-modulated radiation shape the dose tightly around the target, which is essential on the face, where the tumor often sits near the eye and important nerves. Used thoughtfully alongside margin-controlled surgery, radiation makes durable local control achievable even for deep, nerve-involving, or hard-to-remove tumors.

The ways we can treat it.

Postoperative (adjuvant) radiation. Radiation to the surgical area after removal, used when margins are close or positive and re-excision isn't practical, or when the tumor has grown along nerves — it treats microscopic disease and lowers the chance of recurrence.

Definitive radiation. For a tumor that cannot be removed because of size or location, focused external-beam radiation can serve as the primary treatment to control the disease.

Nerve-pathway (perineural) coverage. When the tumor follows nerves, the radiation field is extended along the involved nerve pathways toward their roots to treat disease that surgery cannot reach.

Intensity-modulated radiation (IMRT). Shaping the beams tightly around the target on the face protects the eye, nerves, and other delicate structures while delivering a full dose to the tumor and its nerve pathways.

Questions we hear often.

Is microcystic adnexal carcinoma dangerous? It is a true cancer, but a relatively favorable one because it almost never spreads to other parts of the body. Its challenge is local: it grows deeper and wider than it looks and tends to follow nerves, so it can come back where it started — and damage nearby structures on the face — if it isn't completely removed. With thorough margin-controlled surgery, and radiation when needed, most people are cured.

Why is special surgery (Mohs) often recommended? Because MAC sends out deep, hidden extensions and creeps along nerves well beyond its visible edge, simply cutting out the visible lesion frequently leaves disease behind. Margin-controlled surgery such as Mohs checks the edges of the removed tissue under the microscope, in stages, to trace and clear those hidden extensions — which both improves the cure rate and spares as much healthy facial tissue as possible.

When is radiation used? Surgery is the main treatment, but radiation is added when the surgical edges come back close or involved and further surgery isn't practical, when the tumor has grown extensively along nerves, or as the primary treatment when a tumor can't be removed because of its size or location. The radiation field can be extended along involved nerve pathways to treat disease that surgery cannot reach.

This guide is informational only. It is not medical advice — please confirm anything here with your care team.